April Global Macro Monthly - Inflation to rise, but how fast and for how long?
- 21 April 2021 (7 min read)
Key points
- Virus and vaccines continue to drive growth outlooks. China saw a slower first quarter, but we raise our annual outlook. The Eurozone faces several downside risks, but the outlook is brighter in the UK. Emerging market developments are mixed.
- US activity has also been supplemented by additional fiscal stimulus. We raise our annual growth forecast again. Yet inflation is only expected to rise gradually to target after volatility in 2021.
- The Fed has convinced markets of long-term accommodation for now. The European Central Bank continues to deliver faster Pandemic Emergency Purchase Programme purchases.
- Bond yields have fallen despite ongoing fundamental concerns, in part reflecting the cost of short positions. This has also allowed a bounce in EURUSD. Credit markets have proven a good steer to equity markets and continue to suggest supportive risk outlook.
Disclaimer
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date.
All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document.
Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.